The retinoblastoma protein RB regulates cell proliferation, differentiation and apoptosis. Homozygous knockout of Rb in mice causes embryonic lethality owing to placental defects that result in excessive apoptosis. RB binds to a number of cellular proteins including the nuclear Abl protein and inhibits its tyrosine kinase activity. Ex vivo experiments have shown that genotoxic or inflammatory stress can activate Abl kinase to stimulate apoptosis. Employing the Rb-null embryos as an in vivo model of apoptosis, we have shown that the genetic ablation of Abl can reduce apoptosis in the developing central nervous system and the embryonic liver. These results are consistent with the inhibitory interaction between RB and Abl, and provide in vivo evidence for the proapoptotic function of Abl.
Introduction
The human retinoblastoma susceptibility gene, Rb, encodes a nuclear protein that regulates cell cycle progression, terminal differentiation and programmed cell death (Chau and Wang, 2003; Liu et al., 2004; Nguyen and McCance, 2005) . In mice, the constitutive knockout of Rb causes embryonic lethality resulting from defects in placental function (Clarke et al., 1992; Jacks et al., 1992; Lee et al., 1992; de Bruin et al., 2003; Wu et al., 2003) . The Rb-knockout embryos exhibit inappropriate cell cycle entry and massive apoptosis in the developing central nervous system (CNS), peripheral nervous system, lens, liver and muscles (Clarke et al., 1992; Jacks et al., 1992; Lee et al., 1992) . The excessive apoptosis, but not the ectopic S-phase, of Rb-null embryos is rescued when the embryos are developed on wild-type placentas Wu et al., 2003) .
The mechanism by which RB inhibits cell proliferation is well established. RB interacts with E2F to repress transcription of genes critical for cell cycle progression (Liu et al., 2004; Nguyen and McCance, 2005) . The ectopic cell proliferation in Rb-null embryos is suppressed by the knockout of E2f1 or E2f3, providing in vivo evidence for the critical role of RB in the control of E2F activity (Tsai et al., 1998; Ziebold et al., 2001) . The E2f-knockouts also reduced the apoptosis of Rb-null embryos, consistent with the proapoptotic functions of E2F (Tsai et al., 1998; Ziebold et al., 2001) . Overproduction of E2F-1 in combination with the deprivation of survival signals can lead to activation of p53-dependent apoptosis through the intrinsic death pathway (Hickman et al., 2002; Sherr and McCormick, 2002) . Consistently, the knockout of p53 or Apaf-1 also reduced apoptosis in the Rb-null embryos (Morgenbesser et al., 1994; Macleod et al., 1996; Guo et al., 2001) . These results suggest the Rb-null placental defects can somehow activate the intrinsic apoptotic pathway in the Rb-null embryos. In cultured cells, E2F-1 upregulates the expression of p19Arf, which activates p53 through the sequestration of Mdm2 (Hickman et al., 2002; Sherr and McCormick, 2002) . However, knockout of p19Arf did not rescue the apoptotic phenotype of Rb-null embryos (Tsai et al., 2002) . This result suggests that p53 maybe activated by other pathways to induce apoptosis in the Rb-null embryos.
The RB protein contains several distinct peptidebinding 'pockets' that mediate its interaction with a large number of viral and cellular proteins (Morris and Dyson, 2001; Chau and Wang, 2003) . The interaction between RB and the C-terminal peptide of E2F-1, E2F-2 and E2F-3 has been elucidated by X-ray crystallography to involve the RB A/B domain (Lee et al., 2002; Xiao et al., 2003) . The crystal structure of a shallow groove in the RB B-domain binding to the LxCxE-peptide found in viral oncoproteins such as E7 has also been solved (Lee et al., 1998; Liu et al., 2006) . Recently, the threedimensional structure of RB C-region in complex with an E2F/DP heterodimer has been reported (Rubin et al., 2005) . The RB C-region also interacts with a Pro, Glu, Asn, Phe ('PENF') peptide motif found in several cellular proteins (Darnell et al., 2003) , and a binding site for cyclin-dependent protein kinases (Adams et al., 1999) . A majority of the RB-interacting proteins are regulators of transcription (Morris and Dyson, 2001) . By simultaneous binding multiple proteins, RB can assemble specific promoter complexes to regulate gene expression, and thus control cell proliferation, differentiation and apoptosis (Morris and Dyson, 2001; Hickman et al., 2002; Sherr and McCormick, 2002; Chau and Wang, 2003; Liu et al., 2004; Nguyen and McCance, 2005) .
We have previously shown that the C-region of RB can bind to the Abl tyrosine kinase, leading to the inhibition of kinase activity Wang, 1993,1995) . Subsequent studies of RB C-region binding partners have led to the identification of a 'PENF' motif that is present in Abl, cPLA2, BRCA1, and several other cellular proteins as the motif recognized by the RB 'C-pocket' (Darnell et al., 2003) . The 'PENF' motif is present in the Abl kinase domain, at the C-helix of the kinase N-lobe. Recent crystal structures have demonstrated the orientation of the Abl C-helix to play a critical role in the regulation of Abl activity (Levinson et al., 2006) supporting the conclusion that RB binding to the Abl C-helix causes an inhibition of the tyrosine kinase activity Wang, 1993, 1995) .
Abl is activated by genotoxins and tumor necrosis factor (TNF) to stimulate apoptosis (Agami et al., 1999; Gong et al., 1999; Yuan et al., 1999; Wang, 2000; Chau et al., 2004) . Abl is also activated during amyloid-bpeptide induced neuronal cell death (Alvarez et al., 2004) . The oncogenic BCR-ABL of chronic myelogenous leukemia (CML) can stimulate cell death when it is trapped in the nucleus of CML cells (Vigneri and Wang, 2001; Aloisi et al., 2006) . The Abl tyrosine kinase can activate the apoptotic function of p53 and p73 (Agami et al., 1999; Gong et al., 1999; Sionov et al., 1999; Yuan et al., 1999; Goldberg et al., 2002; Vella et al., 2003) . Therefore, we tested whether Abl might play a role in the apoptotic phenotype of the Rb-null embryos.
The Abl-null mice exhibit neonatal lethality with an array of developmental defects including lymphopenia and osteoporosis (Tybulewicz et al., 1991; Li et al., 2000) . In this study, we combined the Abl-null allele with the Rb-null allele and found that the loss of Abl could rescue apoptosis in a subset of Rb-null tissues between embryonic days E11-E13.
Results
Abl-heterozygosity delayed the death of Rb-null embryos The Abl þ /À (Tybulewicz et al., 1991) and Rb þ /À mice (Jacks et al., 1992) in the 129/sv inbred genetic background were intercrossed to generate compound heterozygous Rb
We did not find any pups with the Rb À/À genotype from mating of the compound heterozygous mice; thus, Abl-knockout did not rescue the lethality of Rb-null embryos. We conducted a large-scale mating, collected a total of 1029 embryos between E10 and E14.5, determined their genotypes and assessed their viability (Figure 1 ). The allele frequency segregated by embryonic days is summarized in Figure 1a . The numbers of embryos collected at E10-E10.5 (n ¼ 83) and E14-E14.5 (n ¼ 78) were not sufficient to obtain a reliable distribution of nine genotypes. We therefore determined the allele frequency among the 1029 embryos (E10-E14.5) and found the nine genotypes to occur according to the Mendelian ratio (Figure 1b) , suggesting a minimum loss of dead embryos by resorption between E10 and E14.5. We then analysed the percentage of dead embryos for each genotype between E10 and E14.5 (Figure 1c) . Death of the Rb À/À Abl þ / þ embryos occurred from E12 through E14.5, consistent with previous reports (Clarke et al., 1992; Jacks et al., 1992; Lee et al., 1992; de Bruin et al., 2003; Wu et al., 2003) . We found a statistically significant reduction (Po0.05) of death with the Rb Figure 1c) . By contrast, the Rb À/À Abl À/À genotype did not prolong embryo survival between E12 and E13.5 ( Figure 1c ). With the 78 embryos collected between E14-E14.5, only one was of the Rb À/À Abl À/À genotype. Although that one embryo was alive (Figure 1c ), the frequency of Rb À/À Abl À/À genotype was much lower than the Mendelian ratio during E14-E14.5 ( Figure 1a ). The knockout of Abl has been shown to cause late embryonic or neonatal lethality in mice (Tybulewicz et al., 1991) . In this study, we also observed a low level (10-20%) of dead embryos with the Rb
and Rb þ /À Abl À/À genotypes between E13 and E14.5 ( Figure 1c ). Taken together, these analyses show that the loss of one Abl allele, but not the complete ablation of Abl, could delay the death of Rb-null embryos.
Rb
À/À erythrocyte differentiation defect not corrected by Abl knockout Rb-deficient embryos exhibit defects in erythropoiesis (Clarke et al., 1992; Jacks et al., 1992; Lee et al., 1992) . During mouse development, nucleated red blood cells derived from the yolk sac are found in embryonic circulation up to E11.5. Mature erythrocytes (enucleated) derived from the embryonic liver start to appear in the circulation around E12. In the Rb À/À embryos, development of enucleated mature erythrocytes is blocked. We examined blood smears from Rb
as well as Rb
embryos at E12.5 and E13.5 to determine the effect of Abl loss on erythroid differentiation (Figure 2 ). At E12.5, blood smears showed B80% of nucleated erythrocytes in embryos of all genotypes examined. At E13.5, the percentage of nucleated erythrocytes was 49% in the blood smears of Rb þ / þ Abl þ / þ embryos, but the level remained close to 80% in Rb À/À embryos irrespective of Abl genotypes (Figure 2 ). This result shows that Abl does not play a role in the erythroid developmental defect of Rb À/À embryos.
Effect of Abl on apoptosis in the developing nervous system of Rb-null embryos The peripheral nervous system (PNS) of Rb À/À embryos undergoes caspase-3 dependent apoptosis, which is (a) The percentages of embryos per genotype on the indicated embryonic days as compared with expected frequency from Mendelian distribution. The embryos (total number under study denoted with n) from the crosses were genotyped on a given embryonic day. The observed frequency of embryos of a given genotype was tabulated as percent of the total number of embryos examined. (b) The percentages of embryos per genotype as compared with expected frequency from Mendelian distribution during the time span between embryonic days 10-14.5. The observed frequency of embryos for a given genotype is expressed as percentages of the total number of embryos examined (n ¼ 1029). The corresponding expected frequency from Mendelian distribution is plotted alongside for comparison. No significant difference exists between the observed and the expected frequencies as determined by unpaired t-test (P>0.05). (c) The frequency of embryonic death per genotype. The percentage of death embryos for a given genotype among the total number of embryos examined on a given embryonic day is plotted as the function of genotype, with different geometric symbols corresponding to the data collected on various embryonic days. The total number of embryos examined on a given day is denoted with n in parenthesis. The embryonic death rate associated with the genotype of Rb
Abl-dependent apoptosis in Rb À/À embryos HL Borges et al readily detected in the sensorial ganglia (Clarke et al., 1992; Jacks et al., 1992; Lee et al., 1992) . To investigate whether Abl is necessary for apoptosis in the developing PNS, sagittal sections of E11.5-E13.5 embryos were processed for TdT-mediated dUTP nick end labeling (TUNEL) assay. As expected, the number of TUNELpositive nuclei in the dorsal root ganglia (DRG) was low in the Rb Figure 3a ) and abnormally high in the Rb (Figure 3b ). The levels of TUNEL-positive nuclei in the DRG remained high in Rb (Figure 3e ). Thus, Abl is not required for the ectopic cell death in the developing Rb À/À PNS. The developing CNS of Rb À/À embryos exhibits increased apoptosis that is reduced by the knockout of E2f-1, E2f-3, p53 or Apaf-1 (Morgenbesser et al., 1994; Macleod et al., 1996; Tsai et al., 1998; Guo et al., 2001; Ziebold et al., 2001; Chau and Wang, 2003) . The abnormal apoptosis is especially intense in the intermediate zone of the hindbrain (Figure 4b ). We found that the knockout of Abl, either one or both alleles, can reduce the CNS apoptosis in a subset of Rbnull embryos, which we denoted as the Type 1 embryos (reduced apoptosis; Figure 4c and d). However, in another subset of Rb-null embryos that we denoted as Type 2, the knockout of Abl exerted no protective effect (excessive apoptosis; Figure 4e and f). Quantification of TUNEL-positive nuclei showed a statistically significant reduction of apoptosis in the Type 1 Rb À/À embryos of either Abl þ /À or Abl À/À genotype (Figure 4g ). The underlying cause for the phenotypic variation between the Type 1 and 2 embryos is unclear; however, we observed an embryonic age-dependence in their occurrence. At E11.5, we found three Rb The differences in the number of TUNEL positive nuclei were statistically insignificant (Dunnett's test P>0.05) among the three genotypes Rb
Abl-dependent apoptosis in Rb À/À embryos HL Borges et al seven (57%) to be of Type 1. At E12.5, we found one Rb Abl À/À embryos out of four (25%) to exhibit the Type 1 phenotype. At E13 and beyond, all of the Rb À/À embryos exhibited the Type 2 phenotype, that is, undergoing CNS apoptosis, irrespective of their Abl genotype. These results show that the loss of one Abl allele is sufficient to reduce the ectopic apoptosis of the developing CNS in the Rb-null embryos but the protective effect of Abl-loss was limited to early embryos.
Besides increased apoptosis, ectopic proliferation is also observed in the CNS of Rb À/À embryos (Clarke et al., 1992; Jacks et al., 1992; Lee et al., 1992) . As discussed in the Introduction, the CNS apoptosis and proliferation phenotypes of Rb-null embryos are differentially rescued by the wild-type placentas Wu et al., 2003) . We assessed the ectopic CNS proliferation by staining sections from E11.5 to E13.5 embryos for the expression of proliferating cell nuclear antigen (PCNA) (Figure 4h-k) . We found similar levels of PCNA-positive nuclei in the intermediate zone of Rb À/À Abl þ /À and Rb À/À Abl À/À embryos irrespective of their apoptosis phenotypes. In other words, similar levels of PCNA-positive nuclei were detected in embryos with the Type 1 and the Type 2 apoptosis phenotypes. Therefore, we found no association between ectopic proliferation and apoptosis in the CNS, nor did we detect any effect of the Abl genotype on the number of PCNA-positive cells (Figure 4h-k) . We also injected the pregnant mother with 5-bromodeoxyuridine (BrdU) 1 h before the harvesting of E13.5 embryos and examined DNA synthesis in the CNS (Figure 5a-d) . Similar to the PCNA-staining result, ectopic proliferation was detected in the intermediate zone of the Rb À/À CNS, but this phenotype was not affected by the Abl genotype (Figure 5b-d and f) . Taken 
Abl-dependent apoptosis in Rb
À/À embryos HL Borges et al together, results in Figures 4 and 5 show that the reduction of CNS apoptosis in Rb-null embryos through Abl deficiency is limited to early embryonic days and independent of ectopic proliferation.
Loss of Abl attenuated cell death in Rb
À/À embryonic liver Increased apoptosis and decreased cellularity have been previously observed in the liver of Rb-null embryos (Clarke et al., 1992; Jacks et al., 1992; Lee et al., 1992; Zacksenhaus et al., 1996) . To investigate whether Abl contributes to this phenotype of Rb-null embryos, sagittal sections of livers from E11.5 to E13.5 embryos were processed for TUNEL assay. The number of TUNEL-positive nuclei was significantly higher in the Rb (Figure 6b and e) than the Rb (Figure 6a and e) , confirming the previous finding of embryonic liver apoptosis that is also caused by the Rb-null placental defect Wu et al., 2003) . We observed a reduction in the liver apoptotic phenotype with the introduction of one Ablnull allele (Figure 6c and e) . The complete loss of Abl further decreased cell death in the liver of Rb-null embryos (Figure 6d and e) . The protection from apoptosis mediated by the loss of Abl in the embryonic 
Abl-dependent apoptosis in Rb À/À embryos HL Borges et al liver was consistently observed in embryos from E11.5 through E13.5 without exception.
Discussion
Results from this study provide the first in vivo evidence for the proapoptotic function of Abl. Previous studies have demonstrated the proapoptotic function of Abl in cultured cell lines or explanted thymocytes (Agami et al., 1999; Gong et al., 1999; Yuan et al., 1999; Wang, 2000; Chau et al., 2004) . With the Rb-null embryos as an in vivo model of apoptosis, we have shown Abl to play a role in the apoptosis of embryonic tissues.
The excessive apoptosis of Rb-null embryos is caused by defects in the placenta because Rb þ / þ placenta completely rescued the apoptotic phenotype of Rb À/À embryos Wu et al., 2003) . While it is clear that apoptosis is the result of placental defects, the actual trigger of death in the developing Rb-null embryos may be variable. Previous studies and the present report have shown that apoptosis of Rb À/À embryos is partially reduced by the knockout of Caspase-3, Apaf-1, p53, E2f-1, E2f-3 or Abl (Table 1) . Each of these gene knockouts exhibited a diverse spectrum of antiapoptotic effects (Table 1) , suggesting different pathways may be activated in distinct embryonic tissues to cause death. Furthermore, our result suggests that the developmental age may also affect the mechanism of CNS apoptosis in Rb-null embryos.
We have found Abl to be required for the Rb-null CNS apoptosis in 50-60% of the E11 embryos, 20-25% of the E12 embryos but not in the E13 embryos. Between E11 and E13, the embryos undergo rapid growth and become dependent on mature erythrocytes (RBC) for oxygen (Kaufman, 1992) . Embryo-intrinsic developmental programs and embryo-extrinsic factors, such as the number of embryos in the litter, determine the kinetics of embryo growth and the switching to RBC. Therefore, phenotypic variations among E11-E13 embryos are not unexpected. We have found that the knockout of Abl did not correct the erythroid differentiation defect. A previous report has suggested that hypoxia caused by the erythroid differentiation defect contributed to the CNS apoptosis in Rb-null embryos (MacPherson et al., 2003) . It is thus possible that the Type 2 embryos, in which CNS apoptosis is not abrogated by Abl loss, might be dying from hypoxia; and that hypoxia-induced CNS death may not require the proapoptotic function of Abl. The Type 1 embryos, in which CNS apoptosis is abrogate by Abl loss, may be dying from metabolic stress that requires the proapoptotic function of Abl.
In the Rb-null genetic background, the proapoptotic activity of Abl may be enhanced owing to the loss of RB control of the nuclear Abl kinase activity. With cultured fibroblasts derived from the Rb À/À Abl À/À embryos, a reduced apoptotic response to TNF-a has previously been reported (Chau et al., 2004) . Whether TNF contributes to the ectopic apoptosis in the CNS or the liver of Rb-null embryos is presently unknown but worthy of further investigation. An unexpected result from this study was the comparable protection from apoptosis by the loss of either one or two alleles of Abl. This finding suggests the proapoptotic function of Abl to exhibit haploid insufficiency such that both alleles of Abl are required to support the excessive apoptosis in the CNS and the liver of Rb-null embryos. This gene dosage effect on the proapoptotic function suggests that a high level of Abl protein, in addition to its tyrosine kinase, is required for the activation of apoptosis. Previous studies have suggested Abl to bind p53 and p73 and to associate with the RB-E2F complex (Welch and Wang, 1993, Abbreviations: Rb, retinoblastoma; CNS, central nervous system; PNS, peripheral nervous system; ND, not determined; +, defect in all embryos; À, defect rescued in all embryos; +/À, defect partially rescued in all embryos; +; À, defect rescued in a percentage of the embryos examined.
Abl-dependent apoptosis in Rb À/À embryos HL Borges et al 1995; Goga et al., 1995; Agami et al., 1999; Gong et al., 1999; Yuan et al., 1999; Goldberg et al., 2002) . In the context of these protein-protein interactions, Abl is shown to stimulate transcription and may thus contribute to p53/p73 and/or E2F-dependent activation of apoptosis Wang, 1993, 1995; Goga et al., 1995; Agami et al., 1999; Gong et al., 1999; Yuan et al., 1999; Goldberg et al., 2002) . A reduction of Abl protein level caused by the loss of one Abl allele may decrease the formation of these proapoptotic transcription complexes, and thus compromise Abl-dependent apoptosis in the Rb-null embryos.
The Abl þ /À mice are healthy and normal; hence, one allele of Abl is sufficient for the proper development of the mouse (Tybulewicz et al., 1991; Li et al., 2000) . It thus appears that the gene dosage-dependent proapoptotic function of Abl, manifested in the Rb-null embryos, is dispensable for normal embryonic development. In the Abl þ /À genetic background, protection from apoptosis is correlated with prolonged survival of the Rb-null embryos. However, reduced apoptosis did not result in prolonged survival in the Rb
À/À mice exhibit a variety of developmental defects leading to late embryonic or neonatal lethality (Tybulewicz et al., 1991; Li et al., 2000) . The Abl protein is localized to the cytoplasm and the nucleus and undergoes nucleo-cytoplasmic shuttling (Wang, 2000; Woodring et al., 2003) . The cytoplasmic Abl is activated by growth factors and cell adhesion to regulate F-actin dynamics (Woodring et al., 2003) . The cytoplasmic functions of Abl are not likely to be regulated by RB; thus, the developmental defects of Abl À/À mice may be owing to defects other than the disruption of ABL/RB interaction. That the Rb À/À Abl À/À embryos did not gain a survival advantage may therefore be explained by the additional developmental defects caused by the homozygous knockout of Abl.
In previous studies, we have found that the knockout of Abl does not affect IR-induced apoptosis in the developing retina of newborn mice (Borges et al., 2004) . However, explanted Abl-null thymocytes exhibit reduced apoptotic response to TNF-a (Chau et al., 2004) and to IR in ex vivo cultures (LD Wood and JYJ Wang unpublished). Others have reported that Abl enhances IR-induced apoptosis in several human cancer cell lines (Yuan et al., 1997 (Yuan et al., , 1999 Agami et al., 1999; Takao et al., 2000) . Our findings of tissue-specific and developmental stage-dependent role of Abl in the apoptosis of Rb-null embryos, together with previously published results, suggest that the proapoptotic function of Abl is modulated by the cell context as well as the nature of the death stimuli. Nevertheless, this study provides in vivo evidence to support the proapoptotic function of Abl.
Materials and methods

Mice embryos Rb
Abl þ /À mice were then inter-crossed to generate embryos for this study (129S6/SvEvTac background). Genotyping was performed as previously described (Tybulewicz et al., 1991; Jacks et al., 1992) . Timed-pregnant females, detected by vaginal plugs (E0.5), were killed and embryos were removed between embryonic days 10.0 and 14.5 (E10.5-E14.5). From the embryos collected, tail DNA was extracted for genotyping and blood smear slides were performed. Blood smear slides were fixed and stained with Wright-Giemsa, according to the manufacturer's instructions (Fisher). Both the viable and the dead embryos were genotyped, whereas only viable embryos were fixed with 10% phosphate-buffered formalin, embedded in paraffin, sagitally sectioned and stained. In some experiments, an intraperitoneal injection (60 mg/kg body mass) of BrdU was given to the pregnant female mice 1 h before the collection of the embryos. The Animal Care and Use Committee of UCSD approved the animal protocols used in this study.
Statistical analysis
Statistical analysis was performed using Prism 4, 2003, from GraphPad Software, Inc. We used paired, unpaired t-test or one-way analyses of variance (ANOVA) (Dunnett's multiple comparison test) to analyse the results. The histograms display the mean and standard error (s.e.m.).
Immunohistochemistry (IHC) and TUNEL assay
Deparaffinized sections were immunostaining with anti-PCNA, (Calbiochem, San Diego, CA, USA), or anti-BrdU (Amersham Biosciences, Pittsburgh, PA, USA) and reveled with anti-mouse Alexa-555 (Promega Corporation, Madison, WI, USA). The tissue sections were then counterstained with 10 mg/ml Hoechst-33258 (Sigma-Aldrich, St Louis, MO, USA). As controls, the primary antibody was omitted from the IHC reactions. TUNEL was performed according to the manufacturer's protocol (Roche Diagnostics Corporation, Indianapolis, IN, USA).
Quantification of TUNEL-positive or BrdU-positive nuclei, and PCNA-positive cells were performed in three to five fields under the microscope ( Â 630 of magnification) in the intermediate zone (the differentiation field) of the hindbrain (CNS) at the fourth ventricle and in the DRG. TUNELpositive nuclei quantification in liver was performed in three to five fields per embryo under the microscope at Â 400 magnification. Quantification was carried out in two to five nonconsecutive sagittal sections from each embryo to decrease the possibility of regional variability. Histograms show the average number of nuclei with the indicated marker (PCNA, BrdU, TUNEL) per mm 2 plus standard error from three to seven embryos. One hundred fifty-four embryos were evaluated by the standard hematoxylin and eosin (H&E) staining to assess viability, tissue structures and to evaluate the presence of pyknotic nuclei. The number of embryos examined by H&E according to genotypes are as follows:
. The number of embryos examined by TUNEL according to genotypes are as follows:
Thus, a total of 84 embryos were processed for TUNEL assays. Embryos that showed high incidence of cell death by H&E staining (presence of pyknotic nuclei) also showed high incidence of TUNEL þ nuclei.
